Senior Program Manager (SPM), Immunology Medical Evidence Generation (MEG)/Life Cycle Management (LCM)
Sanofi
June 25, 2026
Remote friendly (Morristown, NJ)
United States
$122,250 - $176,583.33 USD yearly
Medical Affairs
Main Responsibilities:
- Support building and execution of Global Medical Affairs strategy/plan for Dupilumab related to Integrated Evidence Generation Planning (IEGP).
- Partner with LCM Leads to ensure synergy between IEGP development and financial planning.
- Apply a “Glocal” approach for country inclusion/exchange to identify and prioritize data gaps via two-way interaction between local entities and global stakeholders.
- Implement and execute Medical Evidence Generation operational plans across the dupilumab franchise: data gap generation/prioritization, Medical Brand Planning, IEGP implementation/maintenance, and financial documentation insights; align medical and financial planning for long-range forecasting.
- Coordinate evidence generation insights with affiliate Medical Directors (G10 and beyond) through regular meetings.
- Collaborate with alliance partner Regeneron to define consistent evidence strategy with Research/Clinical Development stakeholders.
- Drive alignment and communication across cross-functional partners (HEVA, Market Access, Translational) and provide reporting to senior leadership and alliance meetings.
- Maintain medical program management tracking tools; ensure compliance with SOPs/guidelines and optimize workflows through harmonized tools.
- Build and maintain internal/external partnerships.
Qualifications (Base):
- BS required; advanced science degree preferred; MBA plus.
- 3+ years project/program management in biotech/pharma or clinical/scientific environment.
- Lead projects end-to-end; strong PM methodology knowledge; collaborate in matrix environments; create KPI dashboards; strong MS Office and PM software skills.
Preferred:
- Biotech/pharma + Project/Program Management; Medical Affairs preferred.
- Alliance environment experience (e.g., Regeneron coordination).
- Strong scientific/data communication and understanding of drug development/commercialization.
Benefits (explicit): rewards package; healthcare/wellbeing programs; at least 14 weeks’ gender-neutral parental leave.
- Support building and execution of Global Medical Affairs strategy/plan for Dupilumab related to Integrated Evidence Generation Planning (IEGP).
- Partner with LCM Leads to ensure synergy between IEGP development and financial planning.
- Apply a “Glocal” approach for country inclusion/exchange to identify and prioritize data gaps via two-way interaction between local entities and global stakeholders.
- Implement and execute Medical Evidence Generation operational plans across the dupilumab franchise: data gap generation/prioritization, Medical Brand Planning, IEGP implementation/maintenance, and financial documentation insights; align medical and financial planning for long-range forecasting.
- Coordinate evidence generation insights with affiliate Medical Directors (G10 and beyond) through regular meetings.
- Collaborate with alliance partner Regeneron to define consistent evidence strategy with Research/Clinical Development stakeholders.
- Drive alignment and communication across cross-functional partners (HEVA, Market Access, Translational) and provide reporting to senior leadership and alliance meetings.
- Maintain medical program management tracking tools; ensure compliance with SOPs/guidelines and optimize workflows through harmonized tools.
- Build and maintain internal/external partnerships.
Qualifications (Base):
- BS required; advanced science degree preferred; MBA plus.
- 3+ years project/program management in biotech/pharma or clinical/scientific environment.
- Lead projects end-to-end; strong PM methodology knowledge; collaborate in matrix environments; create KPI dashboards; strong MS Office and PM software skills.
Preferred:
- Biotech/pharma + Project/Program Management; Medical Affairs preferred.
- Alliance environment experience (e.g., Regeneron coordination).
- Strong scientific/data communication and understanding of drug development/commercialization.
Benefits (explicit): rewards package; healthcare/wellbeing programs; at least 14 weeks’ gender-neutral parental leave.